Search results
Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas. Sun Pharma is the fourth largest global specialty generic pharmaceutical company with a presence in more than 100 countries.
Sun Pharmaceutical Industries Limited (d/b/a Sun Pharma) is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe.
Sun Pharmaceutical Industries Ltd. (Sun Pharma) is the fourth largest specialty generic pharmaceutical company in the world with global revenues of US$ 5.4 billion. Supported by 43 manufacturing facilities, we provide high-quality, affordable medicines, trusted by healthcare professionals and patients, to more than 100 countries across the globe.
About Sun Pharma. Vision & Values. Milestones & Recognitions. Operations. Products. Innovation. Quality. Investors. Financials.
2 days ago · About Sun Pharmaceutical Industries Limited. (CIN - L24230GJ1993PLC019050) Sun Pharma is the world's leading specialty generics company with a presence in specialty, generics and consumer ...
3 days ago · Sun Pharmaceutical Industries Limited Stock Price Today, Live NSE Share Price: Get the latest Sun Pharmaceutical Industries Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
1 day ago · Check out why Sun Pharma share price is up today. Get all details on Sun Pharmaceutical Industries shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more.
Sun Pharma Share Price: Find the latest news on Sun Pharma Stock Price. Get all the information on Sun Pharma with historic price charts for NSE / BSE.
2 days ago · Sun Pharma Ltd, part of the pharma space, witnessed a vertical rise of over 17% after hitting a low above Rs 1,300 levels in June 2024 and if the momentum continues, it could hit fresh record highs.Short to medium-term traders can look at buying the stock for a target around Rs 1,700 levels, suggest experts.The Indian market is stabilising after recent gains, as investors take profits and global markets are weak.
3 days ago · Sun Pharma stocks were trading in the green, up 2.26 per cent at ₹1,656.30 on July 25 at 2:13 pm on the BSE. The company has a market capitalisation of ₹3,97,212.20 crore.
